Aptus Pharma Approves 16.1 Lakh-Share Preferential Issue To 192 Investors

Board approved a proposed preferential issue of 16,10,100 equity shares to 192 investors, subject to shareholder and regulatory approvals; issue price will be determined by the registered valuer and finalized subsequently. AGM scheduled for September 14, 2026, with August 14, 2026 set as the relevant date.